Back to top

Technical picture remains unchanged for LCTX after it falls 3.28% on July 16

Lineage Cell Therapeutics, Inc. (LCTX) — SwingTradeBot Technical Analysis Report · Jul 16, 2026, 17:40 ET
LCTX posted a 3.28% loss on Thursday, July 16th, accompanied by 0.3× normal trading volume. Key support levels exist at 1.16, 1.13 & 1.1, with resistance at 1.21, 1.24 & 1.27. Slow Stochastic readings suggest the stock is currently oversold.

Current SwingTradeBot Technical Rating of LCTX: F

Traders are watching LCTX for a reason. See the full signal list.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Lineage Cell Therapeutics, Inc. (LCTX)